Table 1.

Preoperative patient demographics and tumor characteristics.

Variables	Before PSM (n = 100)			After PSM (n = 69)
	Surgery alone (n = 76)	Triple therapy (n = 24)	P-value	Surgery alone (n = 23)	Triple therapy (n = 46)	P-value
Sex			0.919			1.000
Male	64	20		38	19
Female	12	4		8	4
Age (years)			0.364			0.864
≤ 60	49	13		25	12
> 60	27	11		21	11
HBsAg			0.436			0.448
Yes	65	22		39	21
No	11	2		7	2
Liver cirrhosis			0.294			1.000
Yes	63	22		42	21
No	13	2		4	2
Child-Pugh class			0.701			0.612
A	74	23		45	22
B	2	1		1	1
AFP			0.444			0.601
≤ 400 ng/mL	32	8		19	8
> 400 ng/mL	44	16		27	15
PIVKA-II			0.772			0.693
≤ 400 mAU/mL	18	5		12	5
> 400 mAU/mL	58	19		34	18
No. of tumor			0.652			0.392
Single	34	12		19	12
Multiple	42	12		27	11
Tumor diameter			0.685			0.579
≤ 10 cm	19	7		15	6
> 10 cm	57	17		31	17
ECOG PS			0.079			0.154
0	75	22		45	22
1	1	2		1	1
PVTT			0.736			0.490
Yes	41	12		18	11
No	35	12		28	12
Tbil			0.045			0.178
≤ 23 umol/L	69	18		40	17
> 23 umol/L	7	6		6	6
ALB			0.663			0.606
≤ 40 g/L	31	11		19	11
> 40 g/L	45	13		27	12
ALT			0.508			0.730
≤ 50 U/L	53	15		26	14
> 50 U/L	23	9		20	9
BCLC stage			0.939			0.673
A	14	5		9	5
B	21	7		19	7
C	41	12		18	11
CNLC stage			0.956			0.842
Ib	14	5		9	5
IIa	10	4		10	4
IIb	11	3		9	3
IIIa	41	12		18	11